Y. Kenis

Phase I study of carboplatin given on a five-day intravenous schedule.

Marcel Rozencweig, Claude Nicaise, M. Beer et al. · Journal of Clinical Oncology · 1983 · 64 citations

Medicine, Oncology, Pharmacology +17

Combination chemotherapy with CCNU, vincristine and methotrexate in primary and metastatic brain tumors

Jerzy Hildebrand, J Brihaye, L. Wagenknecht et al. · European Journal of Cancer (1965) · 1975 · 33 citations

Medicine, Oncology, Pharmacology +10

Combination chemotherapy with 1-(2-chloroethyl-3-cyclohexyl-1-nitrosourea) (CCNU), vincristine and methotrexate in primary and metastatic brain tumors—A preliminary report

Jerzy Hildebrand, J Brihaye, L. Wagenknecht et al. · European Journal of Cancer (1965) · 1973 · 30 citations

Medicine, Oncology, Pharmacology +10

Phase I clinical study of 9-hydroxy-2N-methyl-ellipticinium acetate (NSC-264137) administered on a 5-day i.v. schedule

P. Dodion, Marcel Rozencweig, Claude Nicaise et al. · European Journal of Cancer and Clinical Oncology · 1982 · 28 citations

Medicine, Pharmacokinetics, Pharmacology +5

Prognostic value of the superior vena cava syndrome as the presenting sign of small cell anaplastic carcinoma of the lung

P. Van Houtte, Robert De Jager, J Lustman-Maréchal et al. · European Journal of Cancer (1965) · 1980 · 23 citations

Medicine, Oncology, Surgery +7